Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.37
-$0.05-1.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 318.84M | 339.70M | 404.85M | 443.48M | 375.91M |
| Total Receivables | 1.42M | 2.04M | 2.87M | 2.52M | 2.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.57M | 2.19M | 591.00K | 1.18M | 941.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.98M | 1.08M | 1.71M | 926.00K | 674.00K |
| Total Current Assets | 324.81M | 345.01M | 410.02M | 448.10M | 379.95M |
|
|
|||||
| Total Current Assets | 324.81M | 345.01M | 410.02M | 448.10M | 379.95M |
| Net Property, Plant & Equipment | 24.05M | 34.78M | 35.72M | 36.97M | 37.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 660.00K | 5.88M | 5.22M | 4.95M | 4.95M |
| Total Assets | 361.96M | 414.05M | 450.96M | 490.01M | 422.43M |
|
|
|||||
| Total Accounts Payable | 4.23M | 2.44M | 5.37M | 7.01M | 7.17M |
| Total Accrued Expenses | 43.85M | 20.42M | 14.18M | 16.61M | 12.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.50M | 628.00K | 143.00K | 649.00K | 1.64M |
| Total Finance Division Other Current Liabilities | 967.00K | 1.54M | 1.94M | 2.16M | 1.67M |
| Total Other Current Liabilities | 967.00K | 1.54M | 1.94M | 2.16M | 1.67M |
| Total Current Liabilities | 51.55M | 25.03M | 21.64M | 26.42M | 22.65M |
|
|
|||||
| Total Current Liabilities | 51.55M | 25.03M | 21.64M | 26.42M | 22.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.95M | 28.80M | 28.44M | 27.49M | 26.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 79.50M | 53.83M | 50.08M | 53.91M | 49.22M |
|
|
|||||
| Common Stock & APIC | 679.51M | 672.59M | 667.46M | 661.73M | 554.45M |
| Retained Earnings | -397.15M | -312.65M | -267.21M | -225.31M | -180.96M |
| Treasury Stock & Other | 96.00K | 291.00K | 635.00K | -323.00K | -279.00K |
| Total Common Equity | 282.46M | 360.23M | 400.88M | 436.10M | 373.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 282.46M | 360.23M | 400.88M | 436.10M | 373.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 282.46M | 360.23M | 400.88M | 436.10M | 373.21M |
|
|
|||||